Colgate-Palmolive CompanyCLNYSE

Overview Intelligence Charts News Fundamentals DCF Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 55% recommend buying.

Consensus Rating

Buy

22 analysts·High coverage

55%

Rating Distribution

Strong Buy

00%

Buy

1255%

Hold

1045%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 4% above analyst consensus — near fair value expected.

Bear Case

$85.00

-11%

Consensus

$91.91

-4%

Bull Case

$100.00

+5%

Price Range22 analysts

Low

Consensus

High

$85.00

$100.00

Current Target

Current Price

$95.65

Above Target

$3.74

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$3.87(11 analysts)

P/E36x

Current: 36.1x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+3.45%

EPS+6.64%

FY2028

Rev+3.77%

EPS+7.26%

FY2029

Rev+3.20%

EPS+5.55%

Earnings Surprises

Beat rate:100%(12/12 quarters)

Avg surprise:+3.9%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 13, 2026Redburn Partners

Colgate-Palmolive target raised to $93 from $84 at Rothschild & Co Redburn

Target:$93.00

-3.3%from $96.17

Feb 3, 2026Barclays

Colgate-Palmolive price target raised to $88 from $83 at Barclays

Target:$88.00

-4.2%from $91.89

Feb 2, 2026Morgan Stanley

Colgate-Palmolive price target raised to $100 from $87 at Morgan Stanley

Target:$100.00

+10.8%from $90.29

Feb 1, 2026Wells Fargo

Colgate-Palmolive price target raised to $94 from $86 at Wells Fargo

Target:$94.00

+4.1%from $90.29

Jan 31, 2026Goldman Sachs

Colgate-Palmolive price target raised to $94 from $91 at Goldman Sachs

Target:$94.00

+4.1%from $90.29

Jan 30, 2026Piper Sandler

Colgate-Palmolive price target raised to $96 from $88 at Piper Sandler

Target:$96.00

+7.3%from $89.45

Jan 16, 2026Barclays

Colgate-Palmolive price target raised to $83 from $80 at Barclays

Target:$83.00

-1.6%from $84.31

Jan 14, 2026UBS

Colgate-Palmolive price target raised to $93 from $90 at UBS

Target:$93.00

+11.7%from $83.27

Jan 13, 2026Wells Fargo

Colgate-Palmolive upgraded to Equal Weight from Underweight at Wells Fargo

Target:$86.00

+5.0%from $81.93

Jan 6, 2026Piper Sandler

Piper upgrades Colgate-Palmolive on potential 2026 growth acceleration

Target:$88.00

+14.0%from $77.20

Dec 16, 2025Jefferies

Colgate-Palmolive price target lowered to $85 from $86 at Jefferies

Target:$85.00

+7.7%from $78.95

Dec 9, 2025RBC Capital

Colgate-Palmolive upgraded to Outperform from Sector Perform at RBC Capital

Target:$88.00

+15.6%from $76.11

Nov 3, 2025Evercore ISI

Colgate-Palmolive price target lowered to $94 from $100 at Evercore ISI

Target:$94.00

+24.3%from $75.62

Nov 3, 2025Morgan Stanley

Colgate-Palmolive price target lowered to $87 from $96 at Morgan Stanley

Target:$87.00

+13.6%from $76.57

Oct 10, 2025Deutsche Bank

Colgate-Palmolive price target lowered to $86 from $94 at Deutsche Bank

Target:$86.00

+10.5%from $77.81

Oct 8, 2025UBS

Colgate-Palmolive price target lowered to $92 from $99 at UBS

Target:$92.00

+17.0%from $78.64

Oct 3, 2025Piper Sandler

Colgate-Palmolive assumed with a Neutral at Piper Sandler

Target:$84.00

+7.3%from $78.31

Oct 1, 2025Barclays

Colgate-Palmolive price target lowered to $82 from $87 at Barclays

Target:$82.00

+2.6%from $79.94

Aug 4, 2025Morgan Stanley

Colgate-Palmolive price target lowered to $96 from $104 at Morgan Stanley

Target:$96.00

+15.2%from $83.36

Mar 27, 2025Barclays

Colgate-Palmolive price target raised to $89 from $83 at Barclays

Target:$89.00

-4.5%from $93.19

Sep 23, 2024Piper Sandler

Piper Sandler Starts Colgate-Palmolive Company (CL) at Overweight

Target:$121.00

+17.1%from $103.31

Sep 16, 2024Wells Fargo

Wells Fargo Downgrades Colgate-Palmolive Company (CL) to Underweight, 'Epic Run, Normalization Ahead'

Target:$100.00

-5.4%from $105.73

Jul 22, 2024Stifel Nicolaus

Colgate-Palmolive Company (CL) PT Raised to $105 at Stifel

Target:$105.00

+7.1%from $98.08

May 28, 2024Morgan Stanley

Colgate-Palmolive Company (CL) PT Raised to $103 at Morgan Stanley

Target:$103.00

+10.4%from $93.30

May 15, 2024Argus Research

Colgate-Palmolive Company (CL) PT Raised to $107 at Argus

Target:$107.00

+13.1%from $94.57

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance